Use this URL to cite or link to this record in EThOS:
Title: Synthetic studies of natural compounds and their analogues
Author: Yeh, Li-Kuan
ISNI:       0000 0001 3574 9503
Awarding Body: University of London
Current Institution: University College London (University of London)
Date of Award: 1997
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
PART 1. The total synthesis of the cyclic hexadepsipeptide portion on the antibiotic A83586C. The abstract of part 1. A83586C, a novel cyclodepsipeptide isolated from Streptomyces Kamatakensis, exhibits antitumour properties in vitro against a CCRF-CEM human T-cell Leukaemia line (IC50 = 0.0135 μg/mL). The strategy for synthesis of the peptide portion of A83586C can, in principle, be divided into three parts. First, the asymmetric synthesis of 3S- or 3R-piperazic acids via the Evans-Vederas alkylation procedure. Second, the formation of the linear hexapeptide. Third, the intramolecular coupling to form the cyclic depsipeptide. The problem of N,O-acyl shifts during the cyclization of depsipeptides occurs when serine or threonine residues are present. It was therefore decided to form the lactone bond between (2S,3S)-3-hydroxyleucine and threonine in the last step. Three types of fragment condensations were employed in an attempt to synthesis the linear hexapeptide. The successful synthesis used a "1+2+3" condensation procedure. Synthesis of the linear hexapeptide was achieved by coupling specific amino acids using DCC or BOP-CI. 4-Methyl-2-E-pentenic acid was used inplace of (2S,3S)-3- hydroxyleucine in the coupling reaction. The Fmoc group was employed to protect the amino function of N-Me-(R)-alanine. The Z and Bn permanent protecting groups were employed to protect the N1 amine of 3S- or 3R-piperazic acids and the hydroxyl group of N-hydroxylalanine. The carboxylic acid of threonine was protected by formation of the methyl ester. The 4-methyl-2-E-pentenic acid derivative could potentially be converted to the (2S,3S)-3-hydroxyleucine derivative by a Sharpless asymmetric epoxidation procedure from the linear pseudo-hexapeptide.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available